
Friday, December 09, 2022 10:32:27 AM
I got a sell order in @88, but think it will continue up.
Gilead is moving away from HIV and more into this cancer thingy.
That’s not enough in my mind to justify the rise. But I do think as World central banks default and the Fed starts to absorb these other world bank’s debt on foreign currency collapse, private money has to go somewhere safe. Pharma has always been recession proof. Gilead was a great stock to load. Like LNG was 7 years ago. No end is sight there too
Gilead still needs revenue from its new cancer avenues. HIV, they own and always will. Just already built into the $60 stock price

Liked By
Spread the love. Be the first to like this post!
Recent GILD News
- Gilead Sciences Announces $3 Million in Grant Funding to Eight Organizations Addressing HIV Disparities in Rural U.S. Communities • Business Wire • 03/22/2023 04:00:00 PM
- Kite’s Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma • Business Wire • 03/21/2023 01:37:00 PM
- Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479 • GlobeNewswire Inc. • 03/20/2023 12:30:00 PM
- Gilead Exercises Option to License Nurix’s IRAK4 Targeted Protein Degrader Development Candidate, NX-0479 • Business Wire • 03/20/2023 12:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/14/2023 10:21:37 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/14/2023 04:03:53 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 03/02/2023 11:49:23 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/23/2023 09:23:43 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/23/2023 09:19:28 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/23/2023 09:10:55 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 02/22/2023 09:20:52 PM
- Gilead Presents Positive Proof-of-Concept Data for Investigational Combination Regimen of Lenacapavir with Broadly Neutralizing Antibodies as a Potential Twice-Yearly Approach for the Treatment of HIV • Business Wire • 02/22/2023 04:21:00 PM
- Kite Completes Acquisition of Tmunity • Business Wire • 02/22/2023 02:00:00 PM
- Veklury® (Remdesivir) Reduced Risk of Mortality in Hospitalized COVID-19 Patients Across all Variant Time Periods in a Real World Study of More than 500,000 Hospitalized Patients • Business Wire • 02/21/2023 10:30:00 PM
- Gilead Presents New Data From HIV Cure Research Program and Collaborations Exploring Novel Investigational Combinations and Strategies • Business Wire • 02/21/2023 08:01:00 PM
- Trodelvy® Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer • Business Wire • 02/17/2023 02:00:00 PM
- Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023 • Business Wire • 02/14/2023 01:45:00 PM
- Schedule 13g<br /> (sc 13g/a) • Edgar (US Regulatory) • 02/13/2023 08:35:26 PM
- Schedule 13g<br /> (sc 13g) • Edgar (US Regulatory) • 02/13/2023 07:53:09 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/09/2023 04:29:50 PM
- Kite’s Tecartus® CAR T-Cell Therapy Demonstrates Overall Survival Benefit in Three-Year Follow-up of Pivotal ZUMA-3 Trial in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia • Business Wire • 02/09/2023 12:15:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/07/2023 10:48:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 02/07/2023 08:50:56 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 02/06/2023 09:07:07 PM
- Gilead Gets FDA Expanded OK of Trodelvy in Pre-Treated HR+/HER2- Metastatic Breast Cancer • Dow Jones News • 02/03/2023 04:13:00 PM
FEATURED Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • Mar 22, 2023 1:44 PM
FEATURED Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • Mar 22, 2023 10:03 AM
FEATURED E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • Mar 22, 2023 9:41 AM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM
HealthLynked Corp. Awarded Patent 11,600,395 for "Secure Patient Access via Healthcare Service Provider Specific Wireless Access Point" • HLYK • Mar 21, 2023 8:00 AM